Banka BioLoo Ltd. (BANKA) AI Stock Analysis

• Market Cap: ₹681.71M
• Dividend Yield: N/A
• Average Volume (3M): 13.49K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.42
• Revenue Growth: -4.57%
• EPS Growth: 23.01%
• Country: IN
• Employees: 1,111
• Sector: Services
• Sector Strength: N/A
• Industry: Industrial - Pollution & Treatment Controls
• EPS (TTM): -1.00
• Shares Outstanding: 10,846,582
• 10 Day Avg. Volume: 8,574
• 30 Day Avg. Volume: 13,495
• PEG Ratio: >-0.01
• Price to Book (P/B): 2.48
• Price to Sales (P/S): 1.44
• P/FCF Ratio: -11.24
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 41 Neutral
• Price Target: ₹64.00 ▼(-4.16% Downside)

Banka BioLoo Ltd. faces significant financial and technical challenges, with declining revenues, negative profitability, and bearish market momentum. The negative P/E ratio and lack of dividend yield further weaken its valuation. These factors collectively result in a low overall stock score.

Positive Factors

Strategic Partnerships

Partnerships with government and NGOs can provide stable revenue streams and enhance market penetration, supporting long-term growth.

Recurring Revenue Model

Recurring revenue from services like installation and maintenance can stabilize cash flow and provide financial predictability over time.

Industry Focus

Focus on bio-toilets and sustainable sanitation aligns with global sustainability trends, potentially driving long-term demand.

Negative Factors

Declining Revenue

Declining revenue indicates challenges in market demand or competitive positioning, which can affect long-term viability.

Negative Cash Flow

Negative cash flow limits the company's ability to invest in growth opportunities and may necessitate external financing.

Profitability Challenges

Negative profitability can hinder reinvestment in the business and affect long-term sustainability and shareholder returns.

Banka BioLoo Ltd. Business Overview & Revenue Model

Company Description

Banka BioLoo Limited provides products and services for sanitation and waste management system in India. It manufactures, supplies, and installs bio-toilets. The company is also involved in the operation and maintenance of bio-toilets for Indian railways; setting-up of fecal sludge treatment plants and packaged sewage treatment plants; and refurbishment of sewage treatment plants for complexes. The company was incorporated in 2012 and is based in Hyderabad, India.

How the Company Makes Money

Banka BioLoo Ltd. generates revenue through the sale of its bio-toilet systems, which are marketed to both government and private sectors. The company earns income from direct sales of its products, including various models of bio-toilets tailored for different applications, such as individual households, schools, and public facilities. Additionally, BANKA may offer installation and maintenance services as part of its business model, creating a recurring revenue stream. Strategic partnerships with government initiatives and NGOs focused on sanitation projects further enhance its revenue potential. The company may also profit from the sale of biogas and organic fertilizer produced through the bio-digestion process, tapping into the growing demand for sustainable agricultural inputs.

Banka BioLoo Ltd. Financial Statement Overview

Summary

Banka BioLoo Ltd. is experiencing significant financial challenges, including declining revenues, negative profitability, and cash flow difficulties. The balance sheet shows moderate leverage but shrinking equity, indicating financial strain.

Income Statement

Banka BioLoo Ltd. has experienced a decline in revenue and profitability over the years. The gross profit margin has decreased significantly from a strong position, and the company is currently reporting negative EBIT and net income, indicating challenges in profitability and operational efficiency. The revenue growth rate has been negative in the most recent year, highlighting a contraction in sales.

Balance Sheet

The balance sheet shows a moderate debt-to-equity ratio, indicating a balanced approach to leveraging. However, the stockholders' equity has been decreasing, reflecting potential financial strain. The equity ratio remains stable but does not offset the risks associated with declining equity and increasing liabilities.

Cash Flow

Cash flow analysis reveals a negative free cash flow, indicating the company's inability to generate sufficient cash to cover its capital expenditures. The operating cash flow has also turned negative recently, which is concerning for sustaining operations without external financing. The free cash flow to net income ratio is unfavorable, pointing towards cash flow difficulties.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	524.29M	541.74M	499.96M	423.50M	387.51M	304.58M
Gross Profit	248.99M	9.87M	337.57M	368.11M	320.30M	266.47M
EBITDA	-32.98M	-28.60M	41.85M	66.06M	58.91M	39.31M
Net Income	-91.94M	-89.09M	-6.53M	25.39M	31.08M	22.05M
Balance Sheet
Total Assets	0.00	821.55M	774.23M	652.07M	640.54M	463.71M
Cash, Cash Equivalents and Short-Term Investments	46.49M	40.70M	16.88M	13.41M	8.29M	43.35M
Total Debt	0.00	347.28M	259.13M	167.15M	184.96M	116.99M
Total Liabilities	-315.85M	505.70M	376.61M	251.09M	265.52M	163.43M
Stockholders Equity	315.85M	315.13M	397.20M	400.99M	375.02M	300.28M
Cash Flow
Free Cash Flow	0.00	-69.53M	-72.06M	9.40M	-36.00M	53.55M
Operating Cash Flow	0.00	-24.71M	27.63M	73.53M	-4.40M	58.64M
Investing Cash Flow	0.00	-63.44M	-100.69M	-57.18M	-27.17M	-283.29K
Financing Cash Flow	0.00	87.50M	67.76M	-33.29M	9.55M	-36.86M

Banka BioLoo Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 66.78
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BANKA, the sentiment is Negative. The current price of 66.78 is above the 20-day moving average (MA) of 65.80, below the 50-day MA of 71.89, and below the 200-day MA of 76.86, indicating a bearish trend. The MACD of -2.18 indicates Positive momentum. The RSI at 29.32 is Positive, neither overbought nor oversold. The STOCH value of 9.70 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:BANKA.

Banka BioLoo Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SPECIALITY	56 Neutral	₹5.35B	24.39	―	0.87%	6.66%	-21.40%
Sector *	55 Neutral	$13.29B	17.42	10.03%	0.93%	7.13%	-12.93%
MAHEPC	53 Neutral	₹3.59B	26.06	―	―	17.09%	―
BANKA	41 Neutral	₹681.71M	-16.06	―	―	-4.57%	23.01%
IL&FSENGG	40 Underperform	₹3.54B	-205.79	―	―	-6.13%	98.35%

Banka BioLoo Ltd. Corporate Events

Banka BioLoo Releases Unaudited Financial Results for September 2025

Banka BioLoo Limited has announced the publication of its unaudited financial results for the quarter and half-year ending September 30, 2025. These results have been published in the ‘Financial Express’ and ‘Nava Telangana’ newspapers, adhering to the regulatory requirements of the Securities and Exchange Board of India. This timely disclosure underscores the company’s commitment to transparency and regulatory compliance, potentially impacting investor confidence and market positioning.